Cavitation markets BioForce reactor
January 1, 2009
After successfully completing a reverse merger, Cavitation Technologies Inc. is transitioning from a development company into a manufacturing and sales organization to market its BioForce 9000. The modular 18 MMgy unit uses a patent-pending nanotechnology-based cavitation reactor. Feedstocks, alcohol and a catalyst are introduced into the reactor, forcing the formation of bubbles or cavities, which burst under heat and pressure with a force strong enough to create nanoparticles in nanoseconds. The nanoparticles are then bonded together on a molecular level to create high-quality biodiesel.
Advertisement
Advertisement
Upcoming Events
